Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01405183 · ClinicalTrials.gov registry record
Association Between Hepatitis C Infection and Renal Cell Carcinoma
A clinical trial, sponsored by Henry Ford Health System.
- Completed
- Registry status
- 240
- Enrollment target
NCT01405183: Completed study, sponsored by Henry Ford Health System.
NCT01405183 is a clinical trial that has completed, run by Henry Ford Health System. The registered enrollment target is 240 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01405183 has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- 240 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if there is an association between hepatitis C infection and kidney cancer. All patients who are diagnosed with kidney cancer and who will either have a biopsy or surgery will be offered to be tested for hepatitis C. The control group will be colon cancer patients. Both groups would be of recent diagnosis (6 months).
Primary Outcome
Determine the prevalence of hepatitis C infection in newly diagnosed renal cell carcinoma patients
Interventions
- OTHER Hepatitis C testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2011-01 |
| Est. Completion | 2013-09 |
What the finished NCT01405183 record still lists
NCT01405183 is an observational study that tracks outcomes without assigning an intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Hepatitis C testing is the first listed.
NCT01405183 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01405183 about?
NCT01405183 is a clinical study titled "Association Between Hepatitis C Infection and Renal Cell Carcinoma". The purpose of this study is to determine if there is an association between hepatitis C infection and kidney cancer. All patients who are diagnosed with kidney cancer and who will either have a biopsy or surgery will be offered to be tested for hepatitis C. The control group will be colon cancer pa...
What is the current status of trial NCT01405183?
This trial is currently completed. The enrollment target is 240 participants. The study started on 2011-01. Estimated completion is 2013-09.
What interventions are being tested in trial NCT01405183?
The interventions under investigation include: Hepatitis C testing (OTHER).
Who is sponsoring clinical trial NCT01405183?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia